Bevacizumab: no comeback in early breast cancer?

Bartsch, Rupert; Gnant, Michael; Steger, Guenther G

Bartsch, Rupert; Gnant, Michael; Steger, Guenther G.

Afiliação

Bartsch R; Department of Internal Medicine I, Breast Health Center, Comprehensive Cancer Center, Medical University of Vienna, Vienna 1090, Austria. Electronic address: rupert.bartsch@meduniwien.ac.at.
Gnant M; Department of Surgery, Breast Health Center, Comprehensive Cancer Center, Medical University of Vienna, Vienna 1090, Austria.
Steger GG; Department of Internal Medicine I, Breast Health Center, Comprehensive Cancer Center, Medical University of Vienna, Vienna 1090, Austria.

Lancet Oncol ; 16(9): 1001-1003, 2015 Sep.

Article em En | MEDLINE | ID: mdl-26272771

Assuntos

Bevacizumab/administração & dosagem; Neoplasias da Mama/tratamento farmacológico; Recidiva Local de Neoplasia/tratamento farmacológico; Feminino; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Bevacizumab / Recidiva Local de Neoplasia Limite: Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google